B.S. in Biology graduated and M.S. in Molecular Ecology and Biotechnology from Baja California Autonomous University. She is currently furthering her studies through a master’s degree in Engineering and Innovation at CETYS University.
Affiliations
- Member of the Mexican College of Stem Cells and Regenerative Medicine A.C.
- Member of the Mexican Council of Stem Cells for Therapeutic Research Purposes A.C.
- Participant at PAUTA a national societal initiative oriented towards providing children with scientific exposure from distinguished professionals within diverse fields of knowledge.
Academic Experience:
- Management of Hazardous Biological-Infectious Waste
- Professional update with a postgraduate degree in Regenerative Medicine
- Update of Specialized Regenerative Medicine Techniques
- 4th Specialized Course in Regenerative Medicine and Cell Therapy
- 5th Specialized Course in Regenerative Medicine and Cell Therapy
- Certification in HMX Pro Immunology Immuno-Oncology from Harvard University
Events and Courses:
- Professor in “Update of Specialized Regenerative Medicine Techniques”
- 1st International Congress on Regenerative Medicine and Cell Therapy
- 2nd International Congress on Regenerative Medicine and Cell Therapy.
- Speaker in Webinar "Therapeutic effects of MSC in patients with Covid-19"
- Speaker at "5th Specialized Course in Regenerative Medicine and Cell Therapy"
Published Research
- Esquivel D, Mishra R, Soni P, Seetharaman R, Mahmood A, Srivastava A. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients. Stem Cell Rev and Rep. 2021;17(1):144–52. doi: 10.1007/s12015-020-10017-6
- Esquivel D, Mishra R, Srivastava A. Stem Cell Therapy Offers a Possible Safe and Promising Alternative Approach for Treating Vitiligo: A Review. Curr Pharm Des. 2020;26(37):4815-4821. doi: 10.2174/1381612826666200730221446
- Esquivel D, Garza D, Srivastava A. Mesenchymal Stem Cell Therapy: An Alternative Approach to Treat Chronic Obstructive Pulmonary Disease. Stem Cell Res Ther. 2020;4(1):1035.